Molecule Details
InChIKeyCHNBEZLJAQUZEX-AAJGASCFSA-N
Compound Name5-[4-[3-[6-tert-butylsulfonyl-4-[(4,5-dimethyl-1H-pyrazol-3-yl)amino]quinazolin-7-yl]oxypropyl]piperazin-1-yl]-N-[(3S,5S)-5-[(2,6-difluorophenyl)carbamoyl]-1-[(2S)-3,3-dimethyl-2-[[(2R)-2-(methylamino)propanoyl]amino]butanoyl]pyrrolidin-3-yl]pyrazine-2-carboxamide
Canonical SMILESCN[C@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)c2cnc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cn2)C[C@H]1C(=O)Nc1c(F)cccc1F)C(C)(C)C
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Cross-Family
Avg pChEMBL7.75
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P98170 XIAP Homo sapiens Human PF00653 PF21290 PF13920 8.2 IC50 ChEMBL
O43353 RIPK2 Homo sapiens Human PF00619 PF07714 8.0 IC50 ChEMBL;BindingDB
Q13489 BIRC3 Homo sapiens Human PF00653 PF00619 PF21290 PF13920 7.1 IC50 ChEMBL;BindingDB